Free Trial

AEON Biopharma (AEON) SEC Filings & 10K Form

AEON Biopharma logo
$0.46 -0.01 (-1.09%)
As of 10:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent AEON Biopharma SEC Filings

DateFilerForm TypeView
04/21/2025
3:11 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:02 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:45 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G
03/10/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
12:51 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Dauntless Investment Group, LLC (Filed by)
Form SCHEDULE 13G
02/24/2025
1:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:44 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:45 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEF 14A
01/22/2025
3:02 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
Form SCHEDULE 13D
01/13/2025
3:08 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
3:14 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form PRE 14A
01/08/2025
3:15 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
01/07/2025
3:05 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:04 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
01/06/2025
8:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
11/13/2024
3:06 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:08 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
10/07/2024
4:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
8:04 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4/A
09/04/2024
8:52 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:53 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:59 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:49 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:15 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
08/12/2024
3:20 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
08/12/2024
3:15 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
08/05/2024
11:15 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
07/29/2024
3:11 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Grodnensky Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:43 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form S-1/A
07/09/2024
7:06 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:02 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2024
3:27 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:09 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
05/14/2024
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:05 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
05/14/2024
8:14 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEFA14A
05/14/2024
8:15 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form ARS/A
05/03/2024
6:01 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:18 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AEON) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners